This article examines clinical and biological features of DLBCL patients with poor outcomes, and reviews recent studies addressing alternatives to standard front-line management strategies together with unresolved questions.
This review addresses the rationale and evidence for—and the challenges, cost implications, and future development of—proton therapy as an important part of the treatment strategy in Hodgkin lymphoma.
In this paper, the historic and recent evidence supporting the value of breast cancer screening will be described, along with the underpinnings of the current debate over the relative and absolute benefit of regular mammography screening.
In this article we provide a summary of the questions under consideration by the Supreme Court regarding the health care reform legislation, and we explore how the pending decision on this high-profile matter may impact the oncology community.
In this article, we use a case-based approach to focus on the hereditary aspects of the most common GI cancers, including pancreatic, gastric, and colon cancer.
In this article, we endeavor to clarify the role of radiation therapy and chemotherapy in the treatment of ATC; we note important contributions of the historical literature, and we review more contemporary strategies adopted by several renowned institutions.
In this review, we will present the current data on commercially available molecular profiling assays in breast cancer and discuss the challenges surrounding their incorporation into routine clinical practice as prognostic and predictive tools.
This article will present current information about alpha-pharmaceuticals, a new class of targeted cancer therapy for the treatment of patients with CRPC and bone metastases. It will review preclinical and clinical studies of the experimental radiopharmaceutical radium-223 chloride (Alpharadin).
Oncologists and their patients are facing disruptive changes in healthcare, research, and communication. This dramatic increase in the quantity and quality has changed our lives forever. However, many of us remain frustrated with our inability to control this information overload.
This article will review the recent advances that form the current framework of therapy for RCC, as well as summarize key areas of progress and innovation in the evolving treatment paradigms for this disease.
I confess that I have never taken chemotherapy. Strictly speaking this disqualifies me from commenting any further, so I should sign off now. If, however, you don’t mind hearing from one who has administered chemotherapy by the thousands and can bear witness to its effects, then please read on.
Just over a year ago, Alex Trebek introduced the world to Watson. IBM insists that Watson is a decision-support tool, meant to assist and not supplant physicians. How might it work in oncology?
Cancer treatment is undergoing significant developments and entering the new golden era of genomics which has true potentials for the promise of personalized medicine. Large-scale sequencing is changing our understanding of malignant disorders particularly acute myeloid leukemia.
This series of case presentations (five individual cases) will provide oncologists and other healthcare professionals with strategies for evaluating evidence-based data on the latest treatments in metastatic breast cancer (MBC) and the application of that data into the development of individualized approaches to care, including overcoming resistance, in order to optimize management and outcomes for patients.
These interactive CME activities are offered to physicians and other healthcare professionals without charge by CME. 
CancerNetwork presents exclusive coverage from the Miami Breast Cancer Conference, bringing all the top stories to come out of this year's meeting.
CancerNetwork presents exclusive coverage from the annual San Antonio Breast Cancer Symposium. This year's coverage includes a podcast with Kent Osborne plus reports of the top stories from this year's meeting.
CancerNetwork presents exclusive coverage from the American Society of Hematology (ASH) annual meeting, including a podcast, and reports on the top stories from San Diego.
This year's coverage of the annual meeting of the American Society of Clinical Oncology (ASCO) includes podcasts, videos, and write-ups of the most important information to come out of this year's event.- A 54-Year-Old Woman Notes the Abundant Development of Nonpigmented Hair on Her Ears and Nose
- Head and Neck Tumors
- A 45-Year-Old Woman Presents With Severe Back Pain; Examination Reveals Nephrolithiasis
- A 58-Year-Old Man Presents With Abdominal Pain and Jaundice
- Treatment of Castration-Resistant Prostate Cancer: Current Options and Novel Therapies
|
TOPIC INDEX
JOB LISTINGS
Post a job
Powered by SearchMedica Jobs
CONNECT WITH US
|
|
|||||||||||||||||||||||||||||
CancerNetwork |
ConsultantLive |
Diagnostic Imaging |
Musculoskeletal Network |
OBGYN.net |
PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources
© 1996 - 2012 UBM Medica LLC, a
UBM company
Privacy Statement -
Terms of Service -
Advertising Information -
Editorial Policy Statement -
UBM Medica Network Privacy Policy